Biogen Pharmachem Industries Lim (BSE: 531752) is a Rajkot, Gujarat-based company in the Investment Holding Companies industry. With a market capitalisation of ₹27 Cr, it ranks #4,220 by market cap among the 6,197 Indian listed companies on FinBizNet, and #73 of 130 in Investment Holding Companies. At ₹0.29 (as of 16 Nov 2026), the share price is 59.7% below its 52-week high of ₹0.72 and 26.1% above its 52-week low of ₹0.23. The share price is down 58.2% over one year and up 7.4% over three months.
| Current Price | ₹0.29 |
|---|---|
| Market Cap | ₹27 Cr |
| BSE Code | 531752 |
| Sector | Financials > Financial Services > Capital Markets |
| Sub-Industry | Asset Management and Custody Banks > Investment Holding Companies |
| P/E Ratio | 29 |
| Return on Equity | 0.90% |
| Return on Assets | 0.23% |
| 52-Week Range | ₹0.23 – ₹0.72 |
| 1-Year Price Change | -58.2% |
| 3-Month Price Change | +7.4% |
| Beta (1Y) | -0.54 |
| Headquarters | Rajkot, Gujarat |
| Website | www.biogenpharma.club |
Delivery averaged 57.6% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Biogen Pharmachem Industries Limited engages in the trading of shares and securities. The company was formerly known as Sun Techno Overseas Limited and changed its name to Biogen Pharmachem Industries Limited in March 2021. Biogen Pharmachem Industries Limited was incorporated in 1995 and is based in Rajkot, India.
1. Non-Regulated Utility-0 2. Unclassified Services-This segment engages in the business of trading in shares, securities, and small level of stock broking. It also engages in consulting works.
1. Unclassified Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Authum Investment & Infrastructure Limited | ₹49,773 Cr | 9.5 | 13.10% | ₹681 Cr | +3.0% |
| Tata Investment Corp Ltd | ₹29,783 Cr | 68.7 | 1.44% | ₹122 Cr | -24.9% |
| TVS Holdings Ltd | ₹25,892 Cr | 15.2 | 29.42% | ₹20,183 Cr | -15.1% |
| Maharashtra Scooters Ltd. (Bajaj Group) | ₹13,750 Cr | 44.2 | 1.06% | ₹297 Cr | -17.5% |
| Edelweiss Financial Services Limited | ₹12,459 Cr | 23.1 | 11.47% | ₹2,199 Cr | +23.8% |
| Indiabulls Limited (Yaari Digital Integrated Service) | ₹7,083 Cr | 24.8 | — | ₹332 Cr | +43.6% |
| Bengal & Assam Company Ltd. | ₹6,467 Cr | 7.8 | 10.23% | ₹37 Cr | -22.1% |
| Pilani Investment And Industries Corporation Limited | ₹4,481 Cr | 143.9 | 0.20% | ₹187 Cr | -20.6% |
| Biogen Pharmachem Industries Lim | ₹27 Cr | 29 | 0.90% | — | -58.2% |
Listed by market capitalisation. Ratios are shown for context only.
Biogen Pharmachem Industries Lim is trading at ₹0.29, with a market capitalisation of ₹27 Cr.
Biogen Pharmachem Industries Lim operates in the Financials > Financial Services > Capital Markets space (Asset Management and Custody Banks > Investment Holding Companies).
Biogen Pharmachem Industries Lim has a P/E of 29 and a return on equity of 0.90%.
Biogen Pharmachem Industries Lim is listed on the BSE under the scrip code 531752.
Biogen Pharmachem Industries Lim's share price is down 58.2% over one year and up 7.4% over three months. Its 52-week range is ₹0.23 to ₹0.72.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.